You Searched For "first pharmaceutical firm" and got 19 results
Sort By:
Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
"Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use au…
PTI
Twitter verification trolls targeted the pharmaceutical firm Eli Lilly, falsely announcing that 'insulin is free' before claiming it would cost $400-per-vial
Elon Musk's changes to Twitter's verification system are already causing problems, with impersonato…
Pete Syme
JB Pharma acquires four pediatric brands of Dr Reddy’s Labs for ₹98.3 crore
All the four brands have a combined market size of ₹1800 crore and accounted for as much as ₹33 cro…
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
A COVID-19 pill could prevent infected people from getting seriously sick. But the FDA panel expres…
Andrew Dunn,Andrea Michelson
Eli Lilly will be the first trillion-dollar drug company in history, billionaire investor Ken Langone says
Eli Lilly belongs to the small band of pharma stocks that have seen a stellar year, and Langone thi…
Aruni Soni
Business is booming for the maker of weight-loss drugs Wegovy and Ozempic — so much so that it is threatening luxury giant LVMH's crown as Europe's most valuable firm
Novo Nordisk's at-home injections are in high demand, but some insurers say they won't cover the hi…
Grace Dean
Johnson & Johnson's CEO doesn't want to go back to 'business as usual' after the pandemic and hopes public-private partnerships among pharmaceutical firms continue
"I hope we don't go back to doing business as usual," Johnson & Johnson CEO Alex Gorsky said in an …
Allana Akhtar
The Trump administration gave a drug-making contract worth up to $812 million to a small Virginia firm was founded less than 6 months ago
The Trump administration is plowing hundreds of millions into boosting US medicine manufacturing, a…
Tom Porter
Here's the data we have so far on the Omicron variant versus our vaccines — what scientists have found, and what remains unanswered
The first lab findings are flying in from scientists around the world. Here's what we know so far o…
Andrew Dunn,Dr. Catherine Sch…
Warren Buffett's Berkshire Hathaway reveals new bets on Floor & Decor and Royalty Pharma
The famed investor's company also exited Merck and trimmed several holdings including Visa, Masterc…
Theron Mohamed
EQRx has a bold strategy to disrupt biotech
These are Insider's biggest healthcare stories for August 24.
Shelby Livingston
The FDA just fully approved Pfizer's COVID-19 vaccine in a move that could lead to more vaccinations
The shift from emergency use to full approval for the Pfizer-BioNTech shot could spur more people t…
Andrew Dunn
The FDA will allow COVID-19 booster shots for some people with weakened immune systems
The agency's tweak to the emergency OK for COVID-19 vaccines will allow for booster shots for immun…
Andrew Dunn,Cheryl Teh
Kyrsten Sinema takes thousands in campaign contributions from pharmaceutical giants while stalling prescription drug pricing reforms
Since the start of her political career, pharmaceutical companies have lobbied Sinema and financed …
Morgan Keith
Warren Buffett's Berkshire Hathaway sold its Biogen stake last quarter - and slashed its pharmaceutical bets
The famed investor's company also sold some Chevron and General Motors shares, and boosted its stak…
Theron Mohamed
Inovio sinks 26% after US government decides to discontinue funding for next phase of COVID-19 vaccine trial
"The decision results from the changing environment of COVID-19 with the rapid deployment of vaccin…
Carla Mozée
If 2015 was the ‘Year of the API’, why is there a Remdesivir shortage six years later?
Catchphrases don’t cure, actual drugs do. In fact, since 2015, the year when the government…
Management consulting firm McKinsey & Co plans to cut 2,000 jobs after adding 17,000 over the past 5 years: reports
The roles to be cut will include departments like human resources and technology, sources told the …
Hannah Getahun
New data on Eli Lilly's experimental Alzheimer's drug backs a hotly debated scientific theory, but shows mixed benefits for patients
Eli Lilly's treatment reduced a harmful substance in the brains of patients with Alzheimer's diseas…